A detailed history of Concurrent Investment Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 24,540 shares of VTRS stock, worth $328,099. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,540
Previous 27,274 10.02%
Holding current value
$328,099
Previous $290 Million 1.73%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$10.32 - $12.13 $28,214 - $33,163
-2,734 Reduced 10.02%
24,540 $285 Million
Q2 2024

Jul 30, 2024

BUY
$10.05 - $12.02 $154,679 - $184,999
15,391 Added 129.52%
27,274 $290 Million
Q1 2024

May 07, 2024

SELL
$11.27 - $13.53 $12,735 - $15,288
-1,130 Reduced 8.68%
11,883 $142 Million
Q4 2023

Apr 15, 2024

BUY
$8.77 - $10.85 $114,124 - $141,191
13,013 New
13,013 $141 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $16.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.